Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Number of shares and voting rights as at 31 December 2014



Number of shares and voting rights

Article L.233-8-II of Commercial Law (Code de commerce) and

Article 223-16 of the General Regulation of the French Financial Markets Authority

(AMF – Autorité des Marchés Financiers)


Press release

Avignon, January 16th, 2015




31.12.2014


























Total number of outstanding shares forming the capital

- 9,196,225 ordinary shares under ISIN FR0000054694

- 362 shares issued from stock-options under ISIN FR0000054694
9,196,587
Number of shares with double voting rights 2,044,470
Total number of gross voting rights 11,241,057
Number of shares without voting rights

- 9,461 bearer shares in the frame of the liquidity contract
- 9,461
Total number of exercisable voting rights* 11,231,596

*Real number of voting rights = total number of voting rights – number of shares without voting rights




You can receive all financial information of Naturex free of charge by signing up at:

www.naturex.com



  • Financial schedule








    - Annual revenue

    - Annual results

    3 February 2015

    31 March 2015



  • Upcoming events







    - SFAF analysts meeting (Paris)
    2 April 2015


Naturex has been listed since October 1996 on Euronext in Paris, Segment B








NATUREX
Total number of shares comprising the share capital: 9,196,587 (December 2014)

ISIN FR0000054694

 

NATUREX is a component of the CACT, Enternext CAC PEA-PME 150, CAC Small & Mid, CAC Small, Gaïa Index.

Naturex is eligible for the "long only" Deferred Settlement Service (SRD) and French equity plans (PEA and PEA-PME).

Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.

 

TICKER: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY

About Naturex


Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (Food & Beverage, Nutrition & Health and Personal Care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.


Naturex's head office is based in Avignon. The company employs 1,600 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 16 sites in Europe, Morocco, the United States, Brazil, Australia, India and Chili. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.



  • Contacts







Carole Alexandre

Investor Relations

Tel.: +33 (0)4 90 23 78 28

[email protected]





Anne Catherine Bonjour

Actus Finance Press Relations

Tel.: +33 (0)1 53 67 36 93

[email protected]
Thierry-Bertrand Lambert

Chief Financial Officer

Tel.: +33 (0)4 90 23 96 89

[email protected]

Information réglementée
Information relative au nombre total de droits de vote et d'actions composant le capital :

-

Communiqué intégral et original au format PDF :


http://www.actusnews.com/documents_communiques/ACTUS-0-38497-2015.01.16-Nb-of-shares-and-voting-rights_December-2014.pdf

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free



Quelle: Actusnews

Like: 0
Teilen

Kommentare